What Is Selank?
Selank is a short peptide studied in anxiolytic research supplied by Peptegrity for research and educational purposes. This page provides a factual educational overview of Selank, including its classification, biological target, research background, terminology and published study context. It is not a product page and does not provide dosing instructions, treatment recommendations or personal-use guidance.
Type of compound
Selank is a synthetic heptapeptide analogue of the endogenous immunomodulatory peptide tuftsin. It is widely characterized in research as a short peptide investigated for its potential neurotropic and anxiolytic properties [3].
Biological target and mechanism
Research suggests that Selank modulates neurotransmitter systems, specifically influencing GABAergic neurotransmission by affecting the expression of related genes [1]. It has also been shown to inhibit enkephalin-degrading enzymes, which may modulate the concentration of endogenous enkephalins in biological systems [2][4].
Research background
Selank was developed to explore new approaches in peptide-based research, focusing on the central nervous system. Scientists investigate this compound to better understand the molecular mechanisms by which synthetic peptides interact with metabolic pathways and signaling molecules [3].
Current research and development status
Selank is currently an investigational research compound. It is not approved by the FDA or other regulatory bodies for human clinical use, and its application is restricted to laboratory and scientific research contexts.
Published research context
Published studies have examined the molecular activity of Selank in various experimental models, including its impact on enzyme degradation pathways [4] and gene expression in neurotransmitter regulation [1]. Additional research has explored its physiological effects on cardiovascular and respiratory systems in animal models to understand broader biological interactions [5].
Relevant terminology
In laboratory science, an anxiolytic refers to an agent being researched for its potential to reduce or modulate anxiety-like behaviors in experimental models. Neurotransmission refers to the process by which signaling molecules are released and received between neurons, which Selank is studied for influencing [1].
Storage and handling terminology
Research peptides are typically stored in lyophilized (freeze-dried) form at sub-zero temperatures, such as -20°C or -80°C, to maintain structural integrity. Researchers must ensure that once reconstituted, the peptide is handled under sterile conditions to prevent degradation and contamination.
Testing and Certificate of Analysis (COA)
A Certificate of Analysis (COA) is a document issued by a laboratory verifying the purity, identity, and concentration of a chemical compound. Researchers should review these reports to confirm that the batch meets the necessary quality standards for their specific experimental protocols.
Regulatory status
Selank is a research chemical and is not approved by the FDA, TGA, or EMA for therapeutic use in humans. It is intended solely for scientific research and laboratory investigation, and it should not be sold for human consumption.
This page is for research and educational purposes only. It is not intended to provide medical advice, dosing instructions, or treatment recommendations, and does not represent any product as approved to diagnose, treat, cure or prevent any disease. Compounds described here may be investigational or unapproved medicines; regulatory status is summarised for information only.
Frequently asked questions
What is Selank?
Selank is a synthetic heptapeptide that is the subject of ongoing scientific study, primarily regarding its interactions with neurotransmission pathways and enzyme regulation [3].
How is Selank classified?
Selank is classified as a synthetic heptapeptide, an analogue of the endogenous peptide tuftsin, designed for research into neurological and molecular functions [3].
What is the regulatory status of Selank?
Selank is an investigational compound not approved by regulatory agencies for medical or therapeutic use; it is strictly intended for laboratory research purposes.
How does Selank interact with enzymes in research?
Studies have indicated that Selank possesses the ability to inhibit specific enzymes responsible for the degradation of enkephalins in serum [2][4].
Does Selank affect gene expression?
Research has demonstrated that the administration of Selank can influence the expression of certain genes involved in GABAergic neurotransmission, according to studies conducted on experimental models [1].
References
- 1.Selank Administration Affects the Expression of Some Genes Involved in GABAergic NeurotransmissionFrontiers in Pharmacology
- 2.The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activityPubMed
- 3.Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological ActivityPubMed
- 4.Semax and selank inhibit the enkephalin-degrading enzymes from human serumPubMed
- 5.Effects of the new peptide anxiolytic drug selank on the cardiovascular system functioning and respiration in catsPubMed
